2019 Scientific Sessions

SuperSaturated Oxygen in STEMI to Reduce Infarct Size: A New FDA-Approved Therapy

We invite you to dine and learn about a newly approved therapy for anterior STEMI patients to further reduce infarct size. SSO2 Therapy delivers hyperbaric levels of oxygen to the LCMA following successful PCI. Join Gregg Stone, M.D., FSCAI and this esteemed panel to delve into the background, application, and data on SSO2 Therapy.
SuperSaturated Oxygen Therapy: Background and Pre-Clinical Studies
Shukri W. David, MD, FACC, FSCAI, Ascension Providence Hospital, Southfield, MI
SuperSaturated Oxygen Therapy: Clinical Outcomes and Infarct Size Reduction
Gregg W. Stone, M.D., Cardiovascular Research Foundation, New York, NY
Practical Application: Case Presentation
Amir Lotfi, MD, FSCAI, Baystate Medical Center, Sprigfield , MA
See more of: Satellite Sessions